fbpx
May 12, 2023

Ciprofloxacin Oral, Injection products

Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales M100 standard is recognized Salmonella spp. M100 standard is recognized Pseudomonas […]
May 12, 2023

Cefotaxime – Injection products

Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales M100 standard is recognized Acinetobacter spp. ≤1 2 ≥4 – – […]
May 12, 2023

Cefoperazone – Injection products

  Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales ≤ 8 – ≥ 16 – – – Other non-Enterobacterales […]
May 12, 2023

FDA Roundup: May 12, 2023

For Immediate Release: May 12, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]
May 12, 2023

Can Ozempic and Other GLP-1 Drugs Reduce Your Dementia Disease Risk?

Researchers are investigating if popular drugs used for diabetes and weightloss may help prevent cognitive decline and dementia. The drugs, which belong to a class of […]
May 12, 2023

Etrasimod Looks Safe for Ulcerative Colitis Out to 2.5 Years Etrasimod Looks Safe for Ulcerative Colitis Out to 2.5 Years

CHICAGO — A new agent under consideration for approval by the US Food and Drug Administration (FDA) to treat moderately to severely active ulcerative colitis (UC) […]
May 12, 2023

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

For Immediate Release: May 12, 2023 Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe […]
May 12, 2023

From Burned Out Oncologist to Published Novelist From Burned Out Oncologist to Published Novelist

Rural community hematologist-oncologist and long-time Medscape contributor Jennifer Lycette, MD, talks about her dystopian medical novel, The Algorithm Will See You Now, and how she juggled […]
May 12, 2023

FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems

The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0